Report Detail

Pharma & Healthcare Global Nifedipine Market Insights and Forecast to 2026

  • RnM4115185
  • |
  • 05 August, 2020
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Nifedipine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nifedipine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Nifedipine market is segmented into
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets

Segment by Application, the Nifedipine market is segmented into
Primary Pulmonary Hypertension
Heart Failure
Others

Regional and Country-level Analysis
The Nifedipine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nifedipine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nifedipine Market Share Analysis
Nifedipine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nifedipine business, the date to enter into the Nifedipine market, Nifedipine product introduction, recent developments, etc.

The major vendors covered:
Bayer (Germany)
Actavis (USA)
Teva (Israel)
Pfizer (USA)
Shyndec (China)
Honglin (China)
Huanghai (China)
Yabao (China)


1 Study Coverage

  • 1.1 Nifedipine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Nifedipine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Nifedipine Market Size Growth Rate by Type
    • 1.4.2 Nifedipine Controlled Release Tablets
    • 1.4.3 Nifedipine Extended Action Tablets
  • 1.5 Market by Application
    • 1.5.1 Global Nifedipine Market Size Growth Rate by Application
    • 1.5.2 Primary Pulmonary Hypertension
    • 1.5.3 Heart Failure
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Nifedipine Market Size, Estimates and Forecasts
    • 2.1.1 Global Nifedipine Revenue 2015-2026
    • 2.1.2 Global Nifedipine Sales 2015-2026
  • 2.2 Global Nifedipine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Nifedipine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Nifedipine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Nifedipine Competitor Landscape by Players

  • 3.1 Nifedipine Sales by Manufacturers
    • 3.1.1 Nifedipine Sales by Manufacturers (2015-2020)
    • 3.1.2 Nifedipine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Nifedipine Revenue by Manufacturers
    • 3.2.1 Nifedipine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Nifedipine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Nifedipine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Nifedipine Revenue in 2019
    • 3.2.5 Global Nifedipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Nifedipine Price by Manufacturers
  • 3.4 Nifedipine Manufacturing Base Distribution, Product Types
    • 3.4.1 Nifedipine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Nifedipine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Nifedipine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Nifedipine Market Size by Type (2015-2020)
    • 4.1.1 Global Nifedipine Sales by Type (2015-2020)
    • 4.1.2 Global Nifedipine Revenue by Type (2015-2020)
    • 4.1.3 Nifedipine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Nifedipine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Nifedipine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Nifedipine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Nifedipine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Nifedipine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Nifedipine Market Size by Application (2015-2020)
    • 5.1.1 Global Nifedipine Sales by Application (2015-2020)
    • 5.1.2 Global Nifedipine Revenue by Application (2015-2020)
    • 5.1.3 Nifedipine Price by Application (2015-2020)
  • 5.2 Nifedipine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Nifedipine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Nifedipine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Nifedipine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Nifedipine by Country
    • 6.1.1 North America Nifedipine Sales by Country
    • 6.1.2 North America Nifedipine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Nifedipine Market Facts & Figures by Type
  • 6.3 North America Nifedipine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Nifedipine by Country
    • 7.1.1 Europe Nifedipine Sales by Country
    • 7.1.2 Europe Nifedipine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Nifedipine Market Facts & Figures by Type
  • 7.3 Europe Nifedipine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Nifedipine by Region
    • 8.1.1 Asia Pacific Nifedipine Sales by Region
    • 8.1.2 Asia Pacific Nifedipine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Nifedipine Market Facts & Figures by Type
  • 8.3 Asia Pacific Nifedipine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Nifedipine by Country
    • 9.1.1 Latin America Nifedipine Sales by Country
    • 9.1.2 Latin America Nifedipine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Nifedipine Market Facts & Figures by Type
  • 9.3 Central & South America Nifedipine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Nifedipine by Country
    • 10.1.1 Middle East and Africa Nifedipine Sales by Country
    • 10.1.2 Middle East and Africa Nifedipine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Nifedipine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Nifedipine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bayer (Germany)
    • 11.1.1 Bayer (Germany) Corporation Information
    • 11.1.2 Bayer (Germany) Description and Business Overview
    • 11.1.3 Bayer (Germany) Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer (Germany) Nifedipine Products Offered
    • 11.1.5 Bayer (Germany) Related Developments
  • 11.2 Actavis (USA)
    • 11.2.1 Actavis (USA) Corporation Information
    • 11.2.2 Actavis (USA) Description and Business Overview
    • 11.2.3 Actavis (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Actavis (USA) Nifedipine Products Offered
    • 11.2.5 Actavis (USA) Related Developments
  • 11.3 Teva (Israel)
    • 11.3.1 Teva (Israel) Corporation Information
    • 11.3.2 Teva (Israel) Description and Business Overview
    • 11.3.3 Teva (Israel) Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Teva (Israel) Nifedipine Products Offered
    • 11.3.5 Teva (Israel) Related Developments
  • 11.4 Pfizer (USA)
    • 11.4.1 Pfizer (USA) Corporation Information
    • 11.4.2 Pfizer (USA) Description and Business Overview
    • 11.4.3 Pfizer (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Pfizer (USA) Nifedipine Products Offered
    • 11.4.5 Pfizer (USA) Related Developments
  • 11.5 Shyndec (China)
    • 11.5.1 Shyndec (China) Corporation Information
    • 11.5.2 Shyndec (China) Description and Business Overview
    • 11.5.3 Shyndec (China) Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Shyndec (China) Nifedipine Products Offered
    • 11.5.5 Shyndec (China) Related Developments
  • 11.6 Honglin (China)
    • 11.6.1 Honglin (China) Corporation Information
    • 11.6.2 Honglin (China) Description and Business Overview
    • 11.6.3 Honglin (China) Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Honglin (China) Nifedipine Products Offered
    • 11.6.5 Honglin (China) Related Developments
  • 11.7 Huanghai (China)
    • 11.7.1 Huanghai (China) Corporation Information
    • 11.7.2 Huanghai (China) Description and Business Overview
    • 11.7.3 Huanghai (China) Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Huanghai (China) Nifedipine Products Offered
    • 11.7.5 Huanghai (China) Related Developments
  • 11.8 Yabao (China)
    • 11.8.1 Yabao (China) Corporation Information
    • 11.8.2 Yabao (China) Description and Business Overview
    • 11.8.3 Yabao (China) Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Yabao (China) Nifedipine Products Offered
    • 11.8.5 Yabao (China) Related Developments
  • 11.1 Bayer (Germany)
    • 11.1.1 Bayer (Germany) Corporation Information
    • 11.1.2 Bayer (Germany) Description and Business Overview
    • 11.1.3 Bayer (Germany) Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer (Germany) Nifedipine Products Offered
    • 11.1.5 Bayer (Germany) Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Nifedipine Market Estimates and Projections by Region
    • 12.1.1 Global Nifedipine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Nifedipine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Nifedipine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Nifedipine Sales Forecast (2021-2026)
    • 12.2.2 North America: Nifedipine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Nifedipine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Nifedipine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Nifedipine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Nifedipine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Nifedipine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Nifedipine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Nifedipine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Nifedipine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Nifedipine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Nifedipine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Nifedipine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Nifedipine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Nifedipine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Nifedipine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Nifedipine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Nifedipine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Nifedipine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Nifedipine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Nifedipine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Nifedipine. Industry analysis & Market Report on Nifedipine is a syndicated market report, published as Global Nifedipine Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Nifedipine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,026.40
    4,539.60
    6,052.80
    3,634.80
    5,452.20
    7,269.60
    601,731.00
    902,596.50
    1,203,462.00
    328,848.00
    493,272.00
    657,696.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report